2020

DATA ANALYSIS
OF PRE AND POST LOCKDOWN
DATA ANALYSIS ON TOP 10 PHARMACEUTICAL
INDUSTRIES
Introduction
Considering the three important constraints
as time factor, money factor, and attitude of
respondents, it was determined to cover top 10
pharmaceutical companies.
There are different methods to collect data
and suitable method of data collection can be
decided keeping in view the consideration of
time, cost, and reliability of source.
Secondary data collection is comparatively an
easy task. It can be collected from old newspaper
articles and Google. Lot of information is
collected from internet. During the pre and post
lockdown in COVID-19 in year 2020 announced
lockdown from 25 march, ‘Indian
pharmaceutical companies’ strategy is consider
to know the changes in Indian pharmaceutical
companies with respect to changed patent act
 The topic is data analysis on comparative study
on pre and post lockdown effect on the economy
on pharmaceutical industries, than I was
collected the meaningful secondary raw data
from old newspaper articles and most of all data
collected from internet. Than I was filter or
cleaning this raw data to analysis in different
patterns for easy to understand. Finally report
on this.
OBSERVATION:-
When we consider all pharmaceutical industries in
India, we get the Indian pharmaceutical companies
total size is 50Bilion$ in Indian rupees is 3.5 Lakh
crore rupees. All over export from India is close to
17Bilion$ in Indian currency is 1.2 Lakh crore rupees.
20% Drugs are produces in India compare to world
as volume. Total world market compare to volume
than India become in 3rd rank. Total world market as
compare o value than India in 10th rank. More than
1.2Trillion$ overall market 3-4% in share to world.
Indian pharmaceutical sector are highly focus on
generic business. In Indian 17Billion$ export in there
Half of the export are going to the US market
(8Billion$). US generic market is close to 80Billion$,
In Indian as compare to volume is 30%. Indian
pharmaceutical companies are highly depending in
US market.
In India pharmaceutical industries more pressure of
USFDA. 2-3 years below USFDA take action on Indian
pharmaceutical industries as like observation on
drugs, import-export of drugs, and chemical process
on drugs. Until Indian pharmaceutical industries
not fulfill the facilities given from USFDA sector. If
not fulfill this facilities than USFDA not give the
license on production. Indian government more
focuses on health care center. They control pricing on
medicines.
In India there are many fake companies produce
copies of medicines therefore this impact on prices of
industries of pharmacy sector.
The government of India also providing incentives to
encourage investment in pharmaceutical sector and
helping domestic players. Under the automatic route
in the drugs and pharmaceutical sector including the
companies using recombinant technology the
government has permitted 100% foreign direct
investment (FDI). According to report the Indian
government plans to set-up a US$639.56 million
venture capital (VC) fund. The fund is encourage
discovery of new drugs also help the strengthen the
pharma infrastructure.
DATA ANALYSIS AND INTERPRETATION:-
There top 10 pharmaceutical companies in India. We
analysis there share holding as on 31-03-2020 on different
category on number of shares and as percentage.
There also define the effect on economy of
pharmaceutical companies from pre and post lockdown at
covid-19 period where on 25 march there PM Modi
announce the lockdown in India. Where pre lockdown
period from 1-February to 28-March 2020 and post
lockdown period from 4-April to 29-May 2020. Here, I was
give post lockdown period from April because as define
statistics lockdown period also be started from post-
lockdown period. There applying this date from 1-Feb to 29-
May 2020 there difference of 7 days verses price holding
market from February to may 2020.
Share Holding as on 31-03-2020

Lupin Ltd Share Holding as

on 31-03-2020
No. of
Category shares Percentage
Promoters 211,279,648 46.64
Foreign
Institutions 102,745,849 22.68
NBFC and
Mutual
Funds 45,914,807 10.14
Central
Government 1,270,943 0.28
Others 14,294,633 3.16
General
Public 48,434,415 10.69
Financial
Institutions 27,771,432 6.13
Foreign
Promoters 1,286,394 0.28

Lupin Ltd Share Holding as on 31-

03-2020 Percentage
Promoters
Foreign Institutions
NBFC and Mutual Funds
Central Government
Others
General Public
Financial Institutions
Foreign Promoters
Sun Pharmaceutical
Industries Ltd Share
Holding as on 31-03-2020
Category No. of shares Percentage
Promoters 1,312,134,535 54.69
Foreign
Institutions 307,313,174 12.81
NBFC and
Mutual
Funds 258,465,884 10.77
Central
Government 6,430 0
Others 125,742,673 5.24
General
Public 184,796,085 7.7
Financial
Institutions 210,876,189 8.79

Sun Pharmaceutical Industries

Ltd Share Holding as on 31-03-
2020 No. of shares
Promoters

Foreign Institutions

NBFC and Mutual

Funds
Central Government

Others
Alkem
Laboratories Ltd
Share Holding as on 31-03-2020
No. of
Category shares Percentage
Promoters 78,774,497 65.88
Foreign
Institutions 4,348,472 3.64
NBFC and
Mutual
Funds 10,217,665 8.55
Central
Government 288,081 0.24
Others 1,377,115 1.15
General
Public 20,984,292 17.55
Financial
Institutions 3,574,878 2.99

No. of shares
Promoters

Foreign Institutions

NBFC and Mutual

Funds
Central Government

Others

General Public
Aurobindo Pharma
Ltd Share Holding as on 31-03-
2020
No. of
Category shares Percentage
Promoters 286,765,471 48.94
Foreign
Institutions 130,444,701 22.26
NBFC and
Mutual
Funds 70,004,055 11.95
Others 22,369,297 3.82
General
Public 54,753,022 9.34
Financial
Institutions 3,602,063 0.61
Foreign
Promoters 18,000,000 3.07

No. of shares

Promoters
Foreign Institutions
NBFC and Mutual Funds
Others
General Public
Financial Institutions
Foreign Promoters
Torrent
Pharmaceuticals
Ltd Share Holding as on
24-04-2020
No. of
Category shares Percentage
Promoters 120,564,720 71.25
Foreign
Institutions 16,271,341 9.62
NBFC and
Mutual
Funds 14,860,149 8.78
Others 2,637,505 1.56
General
Public 10,885,609 6.43
Financial
Institutions 4,003,396 2.37

No. of shares

Promoters
Foreign Institutions
NBFC and Mutual Funds
Others
General Public
Financial Institutions
Cipla Ltd Share

Holding as on 31-03-2020
No. of
Category shares Percentage
Promoters 120,578,409 14.96
Foreign
Institutions 144,742,733 17.95
NBFC and
Mutual
Funds 136,411,887 16.92
Others 54,658,206 6.78
General
Public 128,306,735 15.91
Financial
Institutions 46,036,140 5.71
Foreign
Promoters 174,907,187 21.69
GDR 594,032 0.07

No. of shares

Promoters
Foreign Institutions
NBFC and Mutual Funds
Others
General Public
Financial Institutions
Foreign Promoters
GDR
Dr. Reddy's
Laboratories Ltd
Share Holding as on 31-03-
2020
No. of
Category shares Percentage
Promoters 44,458,528 26.75
Foreign
Institutions 50,098,326 30.15
NBFC and
Mutual
Funds 14,539,166 8.75
Others 35,434,746 21.32
General
Public 11,935,366 7.18
Financial
Institutions 9,310,000 5.6
GDR 395,950 0.24

No. of shares

Promoters
Foreign Institutions
NBFC and Mutual Funds
Others
General Public
Financial Institutions
GDR
Divi's Laboratories
Ltd Share Holding as on 31-
03-2020
No. of
Category shares Percentage
Promoters 137,969,360 51.97
Foreign
Institutions 50,647,319 19.08
NBFC and
Mutual
Funds 38,933,320 14.67
Others 12,704,556 4.79
General
Public 22,747,977 8.57
Financial
Institutions 2,466,048 0.93

No. of shares

Promoters
Foreign Institutions
NBFC and Mutual Funds
Others
General Public
Financial Institutions
Cadila Healthcare Ltd
Share Holding as on 31-03-2020
Category No. of shares Percentage
Promoters 766,534,434 74.88

Foreign
Institutions 45,142,529 4.41

NBFC and
Mutual Funds 75,075,011 7.33
Central
Government 1,475,658 0.14
Others 21,335,999 2.08

General
Public 57,208,041 5.59

Financial
Institutions 56,970,928 5.56

No. of shares

Promoters
Foreign Institutions
NBFC and Mutual Funds
Central Government
Others
General Public
Financial Institutions
Abbott India Ltd
Share Holding as on 31-
03-2020
No. of
Category shares Percentage
Promoters 0 0
Foreign
Institutions 348,692 1.64
NBFC and
Mutual
Funds 1,017,895 4.79
Others 573,005 2.7
General
Public 3,102,597 14.6
Financial
Institutions 273,065 1.29
Foreign
Promoters 15,934,048 74.99

No. of shares

Promoters
Foreign Institutions
NBFC and Mutual Funds
Others
General Public
Financial Institutions
Foreign Promoters
PRICE HOLDING MARKET FROM FEBRUARY TO MAY
2020
WE DVIED THIS PERIOD INTO TWO TYPE PRE AND POST LOCKDOWN PERIOD

PRE LOCKDOWN PERIOD FROM FEBRUARY TO MARCH

2020

COMPANIES PRICES
sun Dr. Reddy's Divi's Cipla Aurobindo
pharmaceutical lab Lab Ind. pharma
DATE
1-Feb 422.8 3116 1987 442 465
7-Feb 430.8 3165 2087 443 546
14-Feb 428.55 3307 2146 446 514
21-Feb 404.95 3256 2168 435 599
28-Feb 372.9 2925 2106 401 505
7-Mar 400.9 3169 2241 433 509
14-Mar 384.2 2889 2889 425 416
21-Mar 365.25 2898 2898 422 347
28-Mar 338.25 2917 1860 408 392

Torrent Lupin Zydus Abbott Alkem

pharma Ltb candila india Lab
DATE
1-Feb 1905 216 1479 12319 2344
7-Feb 2021 209 1472 14103 2505
14-Feb 2112 208 1475 14785 2649
21-Feb 2235 198 1484 15527 2657
28-Feb 2149 198 1471 15709 2627
7-Mar 2192 168 1436 15602 2638
14-Mar 1980 151 1302 15000 2422
21-Mar 1906 155 1230 14790 2351
28-Mar 1856 155 1241 14140 2355
PRE LOCKDOWN FROM FEBRUARY TO MARCH 2020
ANALYSIS ON LINE PATTERN

PRICE HOLDING MARKET FROM FEB TO

MARCH 2020
18000

16000

14000

DATE
12000

1-Feb
10000
PRICES

7-Feb
8000
14-Feb
6000
21-Feb
4000
28-Feb
2000
7-Mar
0
14-Mar

21-Mar

28-Mar
COMPANIES
 PRE LOCKDOWN PERIOD FROM FEBRUARY TO MARCH
2020

Companies’ priCes as perCentage

Dr.
Sun reddy Divi's cipla aurobindo
pharmaceutical lab. lab ind. pharma
DATE
1-Feb 100% 100% 100% 100% 100%
7-Feb 2% 2% 5% 0% 17%
14-Feb 1% 6% 8% 1% 11%
21-Feb -4% 4% 8% -2% 29%
28-Feb -12% -6% 5% -9% 9%
7-Mar -5% 2% 12% -2% 9%
14-Mar -9% -7% 40% -4% -11%
21-Mar -14% -8% 32% -5% -25%
28-Mar -20% -7% -4% -8% -16%

Torrent Lupin Zydus Abbott Alkem

Lab ltd candila India Lab.
DATE
1-Feb 100% 100% 100% 100% 100%
7-Feb 6% -3% 0% 14% 7%
14-Feb 11% -4% 0% 20% 13%
21-Feb 17% -8% 0% 26% 13%
28-Feb 13% -8% -1% 28% 12%
7-Mar 15% -22% -3% 27% 13%
14-Mar 4% -30% -12% 22% 3%
21-Mar 0% -28% -17% 20% 0%
28-Mar -3% -28% -16% 15% 0%
PRE LOCKDOWN FROM FEBRUARY TO MARCH 2020
ANALYSIS ON LINE PATTERN as percentage%:-

120%

100%

80%
companies
sun pharmaceutical
Dr. reddy lab.
60%
Divi's lab
p cipla ind.
r
aurobindo pharma
i
40% Torrent Lab
c
e Lupin ltd
s Zydus candila

20% Abbott India

Alkem Lab.

0%
DATE 1-Feb 7-Feb 14-Feb 21-Feb 28-Feb 7-Mar 14-Mar 21-Mar 28-Mar

-20%

-40% DATES
Here, we look the previous percentage line graph it’s very easy to
understand than other graph, Also to see situation before
lockdown. Were we considering the 1st value on graph is 1st
February is starting prices of the companies, because we will
understand the companies going to profit as well as lost?
Percentage graph helps to understand the who company price on
peak, and also profit (0+) and lost (0- ). Where also to see in
percentage line graph increases market share of the 10 companies
 POST LOCKDOWN PERIOD FROM APRIL TO
MAY 2020

COMPANIES PRICES
sun Dr. Reddy's Cipla Aurobindo
pharmaceutical lab Divi's Lab Ind. pharma
DATE
4-Apr 375.95 3144 1900 449 382
11-Apr 462.95 3618 2313 579 460
18-Apr 457.1 3931 2332 598 542
25-Apr 486.55 4002 2428 599 623
1-May 465.55 3937 2332 591 625
8-May 469 3983 2301 591 652
15-May 448.6 3733 2334 570 664
22-May 469.4 3894 2324 639 730
29-May 474.25 4073 2395 647 745

Torrent Lupin Zydus

pharma Ltb candila Abbott india Alkem Lab
DATE
4-Apr 2077 95 1216 15826 2269
11-Apr 2555 55 1460 17880 2703
18-Apr 2246 87 1342 16968 2755
25-Apr 2431 87 1360 16438 2520
1-May 2442 81 1359 17667 2608
8-May 2462 79 1295 17734 2588
15-May 2599 79 1231 17632 2472
22-May 2364 87 1244 16452 2496
29-May 2364 88 1252 16728 2261
 PRICE HOLDING MARKET FROM APRIL TO
MAY 2020
20000

18000

16000

14000

12000 DATE
4-Apr
PRICE

10000 11-Apr
18-Apr
8000 25-Apr
1-May
6000 8-May
15-May
4000 22-May
29-May

2000

COMPANIES
 POST LOCKDOWN PERIOD FROM APRIL TO
MAY 2020

Companies’ priCes as perCentage%

Dr.
sun reddy Divi's cipla aurobindo
pharmaceutical lab. lab ind. pharma
DATE
4-Apr -11% 1% -5% 2% -18%
11-Apr 9% 16% 17% 31% -1%
18-Apr 8% 23% 15% 35% 17%
25-Apr 15% 23% 19% 36% 34%
1-May 10% 21% 14% 34% 34%
8-May 11% 22% 13% 34% 40%
15-
May 6% 15% 15% 29% 43%
22-
May 11% 21% 14% 45% 57%
29-
May 12% 25% 18% 46% 60%

Torrent Lupin Zydus Abbott Alkem

Lab ltd candila India Lab.
DATE
4-Apr 9% -56% -18% 28% -3%
11-Apr 34% -75% -1% 45% 15%
18-Apr 18% -60% -9% 38% 18%
25-Apr 28% -60% -8% 33% 8%
1-May 28% -63% -8% 43% 11%
8-May 29% -63% -12% 44% 10%
15-May 36% -63% -17% 43% 5%
22-May 24% -60% -16% 34% 6%
29-May 24% -59% -15% 36% -4%
POST LOCKDOWN PERIOD FROM APRIL TO MAY2020 AS
PERCENTAGE% ANALYSIS AS GIVEN PATTERN:-

80%

60%

40%

20%
sun pharmaceutical
Dr. reddy lab.
Divi's lab
P 0%
cipla ind.
R DATE 4-Apr 11-Apr 18-Apr 25-Apr 1-May 8-May 15-May 22-May 29-May
I aurobindo pharma
C Torrent Lab
E Lupin ltd
-20%
S
Zydus candila
Abbott India
Alkem Lab.
-40%

-60%

-80%

-100% DATES
Here, we look in this percentage graph that the effect
lockdown in the economy of pharmaceutical companies in
India. There stock of market prices continuously increases.
Report:-
From the analysis we were give the important
information that Indian pharmaceutical companies
more needed to India. Covid-19 harmful virus are
came in India and death rate is grow up instantly. We
are in phase we are depend in Indian pharmaceutical
industries and there medicines. Were also percentage
line graph is very useful to understand the profit and
loss of pharmaceutical companies. At February and
March 2020 the production is that’s all minimum but
in April and may 2020 the production medicines and
drugs is double and also profit of pharma companies.
REFERENCE:-
1-https://youtu.be/NdBmAdmNs4U

2-- https://www.moneycontrol.com

3- https://economictimes.indiatimes.com
THANK YOU!